AbbVie
ABBV
#29
Rank
$380.21 B
Marketcap
$214.96
Share price
-1.16%
Change (1 day)
4.44%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of December 2025 : -$3.23 Billion USD

According to AbbVie's latest financial reports the company has -$3.23 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$-$3.23 Billion-195.96%
2024-12-31$$3.36 B-67.64%
2023-12-31$$10.39 B-39.86%
2022-12-31$$17.28 B11.99%
2021-12-31$$15.43 B17.86%
2020-12-31$$13.09 B-260.27%
2019-12-31$-$8.18 Billion-3.24%
2018-12-31$-$8.45 Billion-265.71%
2017-12-31$$5.09 B9.94%
2016-12-31$$4.63 B17.52%
2015-12-31$$3.94 B126.46%
2014-12-31$$1.74 B-61.22%
2013-12-31$$4.49 B33.57%
2012-12-31$$3.36 B-71.82%
2011-12-31$$11.93 B-24.01%
2010-12-31$$15.70 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
$86.77 B-2,788.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$26.53 B-922.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$8.65 B-368.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$18.25 B-665.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$22.61 B-800.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$18.50 B-673.30%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$48.71 B-1,609.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$21.48 B-765.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
$3.25 B-200.78%๐Ÿ‡บ๐Ÿ‡ธ USA